Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland

Abstract

BackgroundGiven the scale of the current obesity epidemic and associated health consequences there has been increasing concern about the economic burden placed on society in terms of direct healthcare costs and indirect societal costs. In the Republic of Ireland these costs were estimated at €1.13 billion for 2009. The total direct healthcare costs for six major obesity related conditions (coronary heart disease & stroke, cancer, hypertension, type 2 diabetes and knee osteoarthritis) in the same year were estimated at €2.55 billion. The aim of this research is to project disease burden and direct healthcare costs for these conditions in Ireland to 2030 using the established model developed by the Health Forum (UK) for the Foresight: Tackling Obesities project.MethodologyRoutine data sources were used to derive incidence, prevalence, mortality and survival for six conditions as inputs for the model. The model utilises a two stage modelling process to predict future BMI rates, disease prevalence and costs. Stage 1 employs a non-linear multivariate regression model to project BMI trends; stage 2 employs a microsimulation approach to produce longitudinal projections and test the impact of interventions upon future incidence of obesity-related disease.ResultsOverweight and obesity are projected to reach levels of 89% and 85% in males and females respectively by 2030. This will result in an increase in the obesity related prevalence of CHD & stroke by 97%, cancers by 61% and type 2 diabetes by 21%. The direct healthcare costs associated with these increases will amount to €5.4 billion by 2030. A 5% reduction in population BMI levels by 2030 is projected to result in €495 million less being spent in obesity-related direct healthcare costs over twenty years.DiscussionThese findings have significant implications for policy, highlighting the need for effective strategies to prevent this avoidable health and economic burden.

7-Hydroxymatairesinol improves body weight, fat and sugar metabolism in C57BJ/6 mice on a high-fat diet

“…The high prevalence of the metabolic syndrome and excessive adipose tissue accumulation (in particular, abdominal obesity) is a major threat to public health, being associated with a substantial decrease in health-related quality of life and an increase in economic costs (1)(2)(3) . Thus, new strategies related to the long-term prevention and reduction of incidence and severity of CVD and type 2 diabetes need to be initiated.…”

Scavenger Receptor Class B type 1 (SR-B1) and the modifiable risk factors of stroke

“…Unfortunately, some researchers expect the prevalence for being overweight and obese to reach dramatic levels in the upcoming years. For example, Keaver et al [110] proposed that the overweight and obesity prevalence will reach 89% and 85% in males and females, respectively, by 2030 in Ireland [110]. Wang et al showed that obesity-induced upregulation of miR-24 could function as a feedback regulator of SR-B1 in obesity [61].…”

Relationship of body mass index and abdominal obesity in rural population of Krasnodarsky kray taken

“…О р и г и н а л ь н ы е р а б о т ы О жирение является независимым фактором риска таких социально-значимых заболеваний, как артериальная гипертензия (АГ), ишемическая болезнь сердца (ИБС), сахарный диабет типа 2 (СД2) [1,2]. Ожирение ухудшает качество жизни, увеличивает расходы на медицинскую помощь [3]. Индекс массы тела (ИМТ) является наиболее часто используемым антропометрическим инструментом для оценки относительного веса и классификации ожирения.…”